首页> 美国卫生研究院文献>Acta Veterinaria Scandinavica >An international multi-centre prospective study on the efficacy of an intraarticular polyacrylamide hydrogel in horses with osteoarthritis: a 24 months follow-up
【2h】

An international multi-centre prospective study on the efficacy of an intraarticular polyacrylamide hydrogel in horses with osteoarthritis: a 24 months follow-up

机译:关节内聚丙烯酰胺水凝胶对骨关节炎马的疗效的国际多中心前瞻性研究:24个月的随访

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPolyacrylamide hydrogel (PAAG) was evaluated recently to treat osteoarthritis (OA) in horses with highly encouraging results; however no long term field-study was done to explore its clinical efficacy and lasting effect. The objective of this study was to evaluate the efficacy of PAAG in improving clinical signs of OA in horses. We hypothesized that lameness grade would significantly improve and the effect would last at least 2 years in osteoarthritic joints treated with PAAG. Forty three horses older than 2 years with OA in only one joint based on clinical evaluation, intra-articular anaesthesia and imaging (radiography) were included in this study. Horses were injected with 2 ml of PAAG into the affected joint and were followed up at 1, 3, 6, 12 and 24 months. Efficacy of PAAG was evaluated by blinded clinical assessment of lameness. Adverse reactions to joint injection were assessed. Data relating to case details, type of activity, joint and limb involved, lameness duration, lameness grading, previous joint treatment, joint effusion grading, radiographic grading, and owner assessment were recorded. Factors associated with the outcome measure “lameness grading” were analyzed using generalized linear mixed model for logistic regression.
机译:背景技术最近评估了聚丙烯酰胺水凝胶(PAAG)在治疗马骨关节炎(OA)方面取得了令人鼓舞的结果。但是,没有进行长期的田间研究来探讨其临床疗效和持久作用。这项研究的目的是评估PAAG改善马OA的临床体征的功效。我们假设在用PAAG治疗的骨关节炎关节中,la足等级会显着改善,并且效果至少持续2年。根据临床评估,关节内麻醉和影像学检查(放射线照相术),仅在一个关节中发生了超过2岁的OA的四十三匹马。给马注射2 ml PAAG到患处,并在1、3、6、12和24个月进行随访。通过对clinical行的盲法临床评估来评估PAAG的功效。评估联合注射的不良反应。记录有关病例详细信息,活动类型,涉及的关节和四肢,la行持续时间,la行分级,先前的联合治疗,关节积液分级,放射线照相分级和所有者评估的数据。使用广义线性混合模型对逻辑回归分析与结果度量“ lam度等级”相关的因素。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号